IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ascendis Pharma A/S

CUSIP: 000000ADR | 1 institutional holders

Quarters

Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2019

Vivo Capital, LLC2,552,237
21.8% of portfolio›$298.7K
StyleTurnoverLocationFiled
Vivo Capital, LLC
2,552,237$298.7K21.8%CoreMediumPalo Alto, CA2020-02-25